AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Persimmon PLC

Regulatory Filings Apr 2, 2020

4683_rns_2020-04-02_cc9ae1e3-bd0b-4fc5-bfb1-1bd0c303c141.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6563I

Persimmon PLC

02 April 2020

2 April 2020

Further Update on Covid-19 - Board Remuneration

Persimmon plc ("Persimmon" or the "Group") today provides a further update on the Group's response to the Covid-19 pandemic.

On 25 March 2020, Persimmon announced a number of measures in response to the COVID-19 pandemic, to ensure the safety and wellbeing of its colleagues, customers and business partners. This included the temporary closure of all sales outlets and an orderly shutdown of its construction sites.

In recognition of the current extraordinary circumstances, the Executive Directors and the Board have agreed to take the following additional steps:

The Executive Directors have elected to take a voluntary, temporary 20% reduction in base salary effective from 1 April 2020, until such time as the Group is able to recommence work on site.
The Executive Directors have also decided to forgo any cash bonuses which may have been payable for 2020.
The Non-Executive Directors will also reduce their fees by 20% commencing 1 April 2020 for the period until site work recommences.

For further information please contact:

Simon Rigby
Kevin Smith
Jos Bieneman
Ellen Wilton
Citigate Dewe Rogerson

Tel: +44 (0) 20 7638 9571

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

FURITMRTMTBMBBM

Talk to a Data Expert

Have a question? We'll get back to you promptly.